Safety and efficacy of low-dose esterified estrogens and methyltestosterone, alone or combined, for the treatment of hot flashes in menopausal women: A randomized, double-blind, placebo-controlled study

James Liu, Adam Allgood, Leonard R. Derogatis, Stephen Swanson, Michael O'Mahony, Bertrand Nedoss, Herbert Soper, Edward Zbella, Svetlana Vladimirovna Prokofieva, Lisa Zipfel, Chun Yuan Guo

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

This study evaluated safety and efficacy of esterified estrogens and methyltestosterone administered alone or in combination for the treatment of hot flashes in menopausal women. The 0.30-mg esterified estrogens and 0.30-mg methyltestosterone combination was the lowest effective dose, and our results are consistent with the known safety profile of estrogen and androgen combination products.

Original languageEnglish (US)
Pages (from-to)366-368
Number of pages3
JournalFertility and sterility
Volume95
Issue number1
DOIs
StatePublished - Jan 2011
Externally publishedYes

Keywords

  • Postmenopausal women
  • esterified estrogens (EE)
  • hormone replacement therapy
  • hot flashes
  • lowest effective dose
  • methyltestosterone (MT)
  • vasomotor symptoms

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Safety and efficacy of low-dose esterified estrogens and methyltestosterone, alone or combined, for the treatment of hot flashes in menopausal women: A randomized, double-blind, placebo-controlled study'. Together they form a unique fingerprint.

Cite this